Prostacyclin ELISA (Urine) 5 Plate

$2,306.00
Catalog
74-PCNHU-E05-URN
The Urinary Prostacyclin ELISA 5 Plate kit is a colorimetric competitive enzyme immunoassay kit for the quantitative determination of urinary prostacyclin metabolites in culture supernatants and urine from any species with results in < 3 hours. Absorbance is read at 405 nm. Quantitate PGI2 by measuring the stable metabolites in one simple assay.

For the quantitative determination of urinary prostacyclin metabolites in culture supernatants and urine from any species. Research Use Only. Not for Use in Diagnostic Procedures.
Prostacyclin (PGI2) is involved in platelet aggregation, vasoconstriction, and reproductive functions (1-3). PGI2 has a half life of 60 minutes in plasma but only 2 to 3 minutes in buffer (3). The production of PGI2 is typically monitored by measurement of 6k-PGF1α and 2,3d-6k-PGF1α. 6-keto-PGF1α is produced by the non-enzymatic hydration of PGI2, and is further metabolized in urine to the 2,3-dinor derivative. A number of pharmaceuticals alter and/or inhibit the synthesis of PGI2 (4). Methods to measure PGI2 in urine typically involve HPLC5 , gas chromatography/mass spectrometry (6), or radioimmunoassay (7,8) and enzyme immunoassay (9) for 6k-PGF1α. Please see instructions for use for references.
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available Worldwide
Range
7.81 - 2,000 pg/mL
Sensitivity
6.58 pg/mL
Sizes
5 x 96 Wells
Sample Types
Cell Culture, Urine
Inc Time Hour
3
Inc Time Overnight
No
Inc Time See Protocol
No
Detection
Colorimetric

Prostacyclin ELISA (Urine) 5 Plate

74-PCNHU-E05-URN

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

An End to Subjective RPR Reading?
An End to Subjective RPR Reading? Development of a Novel Automated Nontreponemal Immunoassay for Syphilis
Discover ALPCO’s novel automated nontreponemal immunoassay for syphilis testing. Reduce subjectivity, improve workflow efficiency, and support faster treatment decisions.
View Now
Variation In Calprotectin Results by Methodology
Same Sample, Different Result? What New Research Reveals About Fecal Calprotectin Variability
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
View Now
ALPCO News
NuvinkaDx Announces Major Milestones for Portfolio Companies GeneProof and ALPCO
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.